Module 2 Flashcards
Central Nervious System (CNS) Stimulants
Cocaine
Amphetamines
Nicotine
Caffeine
Opioids
Morphine
Heroin
Oxycodone
Other drugs
alcohol & cannabis
Produce Novelty
LSD (Lysergic Acid Diethylamide)
Esctasy or MDMA
Reduce anxiety
CNS Depressants:
Benzodiazepines
Barbiturates
Factors of misuse potential
-nature of drug
-route of administration
-amount/frequency of use
-availability
-inherent harmfulness
What drugs DOESNT have withdrawl
Hallucinogens (eg. LSD)
Amphetamines drug classes
Amphetamine
Dextroamphetamine
Methamphetamine
Amphetamine Related Compounds
to methamphetamine
Methylphenidate (Ritalin)
MDMA (Ecstasy)
MDMA (Ecstasy)
Methamphetamine derivative
Feelings of intimacy and empathy, improves intellectual capacities
Neurotoxic (causes neuronal damage & death)
Methylphenidate (Ritalin)
Treat attention deficit hyperactivity disorder (ADHD)
(1) Amphetamine: CNS Effects
decreased sensory input thresehold –> CNs excitation –> overstimulation
(2) Amphetamine: CNS Effects
Temperature-regulation & Feeding centre modified → APPETITE SUPPRESSION
Amphetamine feeling
euphoria & reward
Amphetamines increase
agression & mood swings
Amphetamines therapeutic uses
Narcolepsy (chronic sleep disorder)
ADHD
Amphetamine: Short Term disorders
Chest pain/heart attack
Cardiovascular collapse
Increased respiratory rate
Amphetamine: Short Term effects
euphoria/reward
overstimulation
insomnia
appetite suprresion
increase blood pressure & respiration
Amphetamine: Long Term effects
Chronic sleeping problems (insomnia)
Poor appetite
Anxiety, psychoses, aggressive behaviour
Elevated blood pressure and cardiac rhythm
Amphetamine: Concurrent Use
Sleeping problems due to chronic amphetamine → CNS depressant
Drowsiness from opioids → CNS stimulant
Amphetamine: Tolerance
tolerance to euphoria, appetite loss, and cardiovascualr and respiratory effects
Amphetamine: withdrawl
depression, sleep more, big appetite, lack energy
Cocaine: Duration of action & adminsitration
> 1hr
sniffed, smoked
Cocaine mechanisms of action
1) REUPTAKE INHIBITION
2) POSTSYNAPTIC NEURON ACTIVATION